Several investigators have recently reported the isolation of Haemophilus influenzae strains resistant to ampicillin (1, 2, 5, 10, (13) (14) (15) (16) (17) . The majority of these were clinical isolates from meningitis patients responding poorly to ampicillin therapy. In most cases, these patients have responded to subsequent chloramphenicol therapy, although two died. It is now extremely important for clinicians to anticipate the possibility of ampicillin resistance in H. influenzae and to have available prompt and precise means of detecting these resistant strains. Determination of antibiotic susceptibility usually requires 48 h from the time a clinical specimen is collected. However, one characteristic that uniquely distinguishes an ampicillin-resistant strain of H. influenzae is the constitutive elaboration of a f3-lactamase (4, 5, 11 medicine, reliable methods of detection and safe therapeutic alternatives are necessary. Susceptibility studies must now be regularly performed on all clinical isolates, as recently emphasized by Thornsberry and Kirven (12) . The use of tests to detect ,8-lactamase production can save valuable time (11) . The use of the chromogenic substrate assay described herein has several advantages over either the phenol red assay or the iodine starch assay. Buffer and pH control are not as critical as in the phenol red assay. There is no nonspecific reaction like that often observed with cephalosporins in the iodine starch assay (17) . In addition, the chromogenic substrate assay is simple and very rapid. We have encountered neither false-positive nor false-negative results with this test when used to detect f,-lactamase production. Without exception, strains of H. influenzae deemed resistant to ampicillin by susceptibility tests did produce a ,3-lactamase.
Application of the chromogenic substrate method to body fluids, particularly cerebrospinal fluid, should be studied.
The therapeutic dilemma faced by clinicians treating patients with serious Haemophilus infections is by no means resolved. The use of ampicillin as the sole therapeutic agent before the results of susceptibility studies are available demands intense clinical vigilance. Nelson (6) has recently stressed the importance of repeating the lumbar puncture with cerebrospinal fluid smears and cultures plus blood cultures on the day after starting therapy, if ampicillin is used alone. Two deaths have occurred during ampicillin therapy for Haemophilus meningitis due to resistant strains (12) .
Chloramphenicol is reliably active against all strains of H. influenzae and has been used successfully in the treatment of meningitis. Potential hematologic toxicity makes it a less than ideal agent. Carbenicillin, ticarcillin, and tetracycline are all active in vitro against most strains of H. influenzae, but several isolates were inhibited only at 32 gug/ml or greater. Those organisms resistant to ampicillin were least susceptible to carbenicillin and ticarcillin. This may indicate some instability of these compounds to the Haemophilus f3-lactamases.
The cephalosporin antibiotics have not been widely used in the treatment of serious infections due to H. influenzae, especially meningitis. This reflected the availability of a more active drug with better penetration into the cerebrospinal fluid.
Among the newer cephalosporins only cefamandole has in vitro activity comparable to chloramphenicol. In contrast to carbenicillin and ticarcillin, cefamandole is equally active against ampicillin-susceptible and -resistant Haemophilus. Whether adequate concentrations will enter the cerebrospinal fluid to translate these attributes into clinical efficacy is yet to be determined. Cefoxitin is somewhat less VOL. 8, 1975 on September 12, 2017 by guest http://aac.asm.org/ Downloaded from active than cefamandole but, like cefamandole, is resistant to hydrolysis by the Haemophilus f3-lactamases.
Of the orally active cephalosporins tested, compounds 110264 and 99638 were most active. These may prove useful for treating less serious Haemophilus infections, i.e., otitis media.
